ETFs
H
HRTX
Heron Therapeutics Inc
0.7992
-0.0043-0.54%After Hours: 0.7993 +0.0001 +0.01%19:55 04/02 EDT
OPEN/PREV CLOSE0.7859/0.8035
TODAY RANGE0.7700-0.8084
VOL913.79K
MARKET CAP150.68M
52 WEEK RANGE0.7362-2.610
AVG VOL (3M)1.79M
% TURNOVER0.48%
TURNOVER--
P/E (TTM)-6.5995
% RANGE4.78%
EPS(TTM)-0.1211
P/E(FORWARD)-53.2800
P/B10.50
BVPS0.0761
DIVIDEND--
P/S0.9716
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP148.27M
SHARES OUTSTANDING188.54M
NEXT EARNINGS05/04-05/08
FREE FLOAT185.53M
LOT SIZE1
EX-DATE01/13/2014
News
Press Releases
Financial Reports
Profile
TipRanks·03/06 00:20
Heron Therapeutics Signals Profitable Growth After Strong Quarter
NASDAQ·02/26 21:26
Heron (HRTX) Q4 2025 Earnings Call Transcript
TipRanks·02/26 13:22
Heron Therapeutics reports Q4 EPS (2c) vs 2c last year
TipRanks·02/26 13:22
Heron Therapeutics sees FY26 revenue $173M-$183M
Reuters·02/26 13:10
Heron Therapeutics Q4 revenue dips as Acute Care segment holds fort
Dow Jones·02/26 13:06
*Heron Therapeutics Sees 2026 Rev $173M-$183M >HRTX
Seeking Alpha·02/26 13:05
Heron Therapeutics reports mixed Q4 results; introduces FY26 outlook
Dow Jones·02/26 13:05
*Heron Therapeutics 4Q Sales $40.6M >HRTX
Benzinga·02/26 13:02
Earnings Breakdown: Heron Therapeutics Q4
Reuters·02/26 13:01
Heron posts FY 2025 APONVIE net revenue USD 11.6 million up 2.6x
Same Industry
Name/Symbol
Change%
Price